News
HSY to Report Q3 Earnings: Should You Expect a Beat This Time?
The Hershey Company HSY is likely to register an increase in the top line when it reports third-quarter 2025 earnings on Oct. 30. The Zacks Consensus Estimate for Hershey’s quarterly revenues is
Do Options Traders Know Something About ResMed Stock We Don't?
Investors in ResMed Inc. RMD need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $155.00 Call had some of the highest implied
KMB to Report Q3 Earnings: Should You Expect a Beat This Time?
Kimberly-Clark Corporation KMB is likely to register a decrease in both top and bottom lines when it reports third-quarter 2025 earnings on Oct. 30. The Zacks Consensus Estimate for Kimberly-Clark’s
Here's What Key Metrics Tell Us About BCB Bancorp (BCBP) Q3 Earnings
For the quarter ended September 2025, BCB Bancorp (BCBP) reported revenue of $26.46 million, up 1.1% over the same period last year. EPS came in at $0.22, compared to $0.36 in the year-ago quarter.
Should Sprouts Farmers Stock Be in Your Portfolio Pre-Q3 Earnings?
With Sprouts Farmers Market, Inc. SFM set to announce its third-quarter 2025 earnings results on Oct. 29, after the market closes, investors are faced with a crucial decision: Should you add SFM to
Willis Towers Gears Up to Report Q3 Earnings: Here's What to Expect
Willis Towers Watson Public Limited Company WTW is expected to register an improvement in its bottom line but a decline in the top line when it reports third-quarter 2025 results on Oct. 30, before
UDR Set to Report Q3 Earnings: What's in Store for the Stock?
UDR Inc. UDR, a premier multifamily real estate investment trust (REIT), is set to announce its third-quarter 2025 results after the closing bell on Oct. 29. Its quarterly results are likely to
Pre-markets Pick Up Where They Left Off Last Week
Monday, October 27, 2025Pre-market futures continue their ascent to start a new week of trading, despite starting slowly with new data, either for Q3 earnings or economic reports. The Dow is +246
Emerging Market ETF (EMCS) Hits Fresh 52-Week High
For investors seeking momentum, the Xtrackers MSCI Emerging Markets Climate Selection ETF (EMCS) is probably on the radar now. The fund just hit a 52-week high and is up 48.3% from its 52-week low
Dayforce to Report Q3 Earnings: What's in Store for the Stock?
Dayforce DAY is scheduled to release third-quarter 2025 results on Oct. 29.For the to-be-reported quarter, DAY expects revenues to be between $476 million and $486 million. Excluding float, total
Stride to Report Q1 Earnings: Time to Buy or Sell This School Stock?
Stride, Inc. LRN is scheduled to report its first-quarter fiscal 2026 results on Oct. 28, after market close.In the last reported quarter, the company’s adjusted earnings per share (EPS) and total
Why Procter & Gamble Remains a Buy-and-Hold Favorite
Procter & Gamble (NYSE: PG) is a good bet for long-term total returns because its stock price is near the low end of its historical P/E range, its yield is near the high end of its range, and
Is Build-A-Bear's Asset-Light Model the Key to Sustainable Growth?
Build-A-Bear Workshop, Inc.’s BBW asset-light strategy is emerging as a key driver of its growth momentum. The company’s partner-operated retail model is enabling rapid international expansion
RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised
Revvity, Inc. RVTY reported third-quarter 2025 adjusted earnings per share (EPS) of $1.18, which beat the Zacks Consensus Estimate of $1.14 by 3.5%. The bottom line, however, declined 7.8% from the
Eni Q3 Earnings & Revenues Beat on Higher Hydrocarbon Production
Eni S.p.A E reported third-quarter 2025 adjusted earnings from continuing operations of 90 cents per American Depository Receipt, which beat the Zacks Consensus Estimate of 73 cents. The bottom line
Vertex (VERX) Earnings Expected to Grow: Should You Buy?
Vertex (VERX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Vertex Pharmaceuticals (VRTX) reports results for the quarter ended September 2025. While this widely-known
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q3 Release
Wall Street expects a year-over-year increase in earnings on higher revenues when TG Therapeutics (TGTX) reports results for the quarter ended September 2025. While this widely-known consensus
QuinStreet (QNST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects QuinStreet (QNST) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Transcat, Inc. (TRNS) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Transcat, Inc. (TRNS) reports results for the quarter ended September 2025. While this widely-known consensus
Palomar (PLMR) to Report Q3 Results: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Palomar (PLMR) reports results for the quarter ended September 2025. While this widely-known consensus outlook is
Krystal Biotech, Inc. (KRYS) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Krystal Biotech, Inc. (KRYS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known
Palantir Technologies Inc. (PLTR) Earnings Expected to Grow: Should You Buy?
The market expects Palantir Technologies Inc. (PLTR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This


